登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002552 证券简称：宝鼎科技（维权） 公告编号：2026-001 本次业绩预告相关财务数据未经会计师事务所审计。公司就业绩预告有关事项已与公司年报审计会计师 事务所进行了沟通，双方不存在分歧。 宝鼎科技股份有限公司 2025年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 一、本期业绩预计情况 1、业绩预告期间：2025年1月1日至2025年12月31日 2、业绩预告情况：预计净利润为正值且属于同向下降50%以上情形 ■ 注：本公告中的"万元"均指万元人民币。 二、与会计师事务所沟通情况 三、业绩变动原因说明 公司预计归属于上市公司股东的净利润比上年同期下降43.46%至56.39%，主要原因是：1）上年同期收 到业绩补偿金额26,970.41万元导致的营业外收入增加，该事项属于非经常性损益，本报告期无此业务； 2）覆铜板及铜箔业务毛利率及盈利能力下降。 公司预计归属于上市公司股东的扣除非经常性损益的净利润比上年同期增长535.18%至661.78%，主要 原因是黄金价格持续上涨导致的 ...

Core Viewpoint - The company, GeKowei Co., Ltd., anticipates a significant increase in revenue for the year 2025, while projecting a substantial decline in net profit compared to the previous year [2][3]. Group 1: Performance Forecast - The company expects to achieve an operating revenue of between 750 million to 800 million yuan in 2025, representing an increase of 111.67 million to 161.67 million yuan, or a growth of 17.49% to 25.33% year-on-year [2]. - The projected net profit attributable to the parent company is estimated to be between 38 million to 57 million yuan, which indicates a decrease of 12.98 million to 14.88 million yuan, or a decline of 69.49% to 79.66% year-on-year [2]. - The net profit after deducting non-recurring gains and losses is expected to be between -110 million to -75 million yuan, reflecting a decrease of 145.66 million to 180.66 million yuan, or a decline of 206.15% to 255.68% year-on-year [2]. Group 2: Previous Year Performance - In 2024, the company reported an operating revenue of 638.33 million yuan, with a total profit of 124.54 million yuan and a net profit attributable to the parent company of 186.81 million yuan [2]. Group 3: Reasons for Performance Changes - The increase in revenue is primarily driven by the rising shipment volumes of 32 million and 50 million pixel image sensors, with total shipments exceeding 100 million units, and the products being widely used by various brand clients [3]. - The company has faced significant foreign exchange losses due to a depreciation of the US dollar against the Chinese yuan, impacting its dollar-denominated net exposure [3]. - Non-recurring gains and losses, particularly government subsidies recognized in the current period, have also influenced net profit [3].

截至2026年1月28日收盘，海翔药业(002099)报收于6.35元，上涨1.28%，换手率2.09%，成交量33.69万 手，成交额2.14亿元。 当日关注点 浙江海翔药业股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为-13,500万元 至-9,000万元，扣除非经常性损益后的净利润为-14,200万元至-9,500万元，基本每股收益为-0.08元 至-0.06元。与上年同期相比亏损幅度收窄。业绩变动主要原因包括医药板块受产品价格波动、原材料 价格上涨影响，毛利率承压；染料板块核心产品价格上涨，盈利能力修复；美元兑人民币汇率走低对净 利润产生较大负面影响。本业绩预告未经审计，与会计师事务所无重大分歧。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：1月28日主力资金净流入2552.54万元，散户资金净流出2814.74万元。 来自业绩披露要点：海翔药业预计2025年全年归属净利润亏损9000万元至1.35亿元，亏损幅度较 上年同期收窄。 来自公司公告汇总：海翔药业获地夸磷索钠化学原料药 ...

截至2026年1月28日收盘，九强生物(300406)报收于13.89元，下跌2.87%，换手率2.43%，成交量10.31万 手，成交额1.44亿元。 当日关注点 交易信息汇总 资金流向 九强生物发布业绩预告，预计2025年全年扣非后净利润盈利1.71亿元至2.11亿元。九强生物发布业绩预 告，预计2025年全年归属净利润盈利1.8亿元至2.18亿元。 公司公告汇总 2025年度业绩预告 北京九强生物技术股份有限公司发布2025年度业绩预告，预计归属于上市公司股东的净利润为18,000万 元至21,800万元，较上年同期下降66.21%至59.07%。扣除非经常性损益后的净利润预计为17,093万元至 21,093万元，同比下降67.16%至59.48%。业绩下降主要由于控股子公司美创公司受医疗行业政策影响， 拟计提商誉减值准备约1.8亿元，以及主营业务受政策影响导致盈利能力下滑。非经常性损益对净利润 的影响为707万元，主要为政府补助。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自【交易信息汇总】：1月28日主力资金净流 ...

业绩预告 国际复材发布业绩预告，预计2025年全年扣非后净利润盈利2.4亿元至3.3亿元。国际复材发布业绩预 告，预计2025年全年归属净利润盈利2.6亿元至3.5亿元。 公司公告汇总 截至2026年1月28日收盘，国际复材(301526)报收于8.33元，上涨5.84%，换手率15.17%，成交量212.98 万手，成交额17.49亿元。 当日关注点 交易信息汇总 资金流向 1月28日主力资金净流入4705.19万元；游资资金净流入1468.16万元；散户资金净流出6173.35万元。 业绩披露要点 董秘： 感谢您的提问，根据中国证券登记结算有限责任公司定期持有人名册查询（2026年1月20日数 据），公司股份持有人数（已合并）为75,733人。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：1月28日主力资金净流入4705.19万元，散户资金净流出6173.35万元。 来自业绩披露要点：国际复材预计2025年全年扣非后净利润盈利2.4亿元至3.3亿元。 来自公司公告汇总：国际复材预计2025年度归属于上市公司 ...

Core Viewpoint - ST Tian Sheng (002872.SZ) is forecasting a net loss for the fiscal year 2025, with expected losses ranging from 52 million to 76 million yuan, compared to a loss of 87.4 million yuan in the same period last year [1] Financial Performance - The projected net loss attributable to shareholders is between 52 million and 76 million yuan for 2025, which is an improvement from the previous year's loss of 87.4 million yuan [1] - The net profit after deducting non-recurring gains and losses is expected to be a loss of 60 million to 88 million yuan, compared to a loss of 110 million yuan in the previous year [1] Reasons for Loss - The primary reason for the company's losses is attributed to high fixed costs, particularly depreciation expenses related to fixed assets [1] - The anticipated reduction in losses for 2025 is mainly due to a decrease in the provision for fixed asset impairment compared to the previous year [1]

格隆汇1月28日丨宝鼎科技（维权）(002552.SZ)发布2025年度业绩预告，报告期内，归属于上市公司股 东的净利润1.08亿元至1.40亿元，同比减少43.46%至56.39%；扣除非经常性损益后的净利润1.10亿元至 1.42亿元；基本每股收益0.28元/股至0.36元/股。 报告期内，公司预计归属于上市公司股东的净利润比上年同期下降43.46%至56.39%，主要原因是：1） 上年同期收到业绩补偿金额26,970.41万元导致的营业外收入增加，该事项属于非经常性损益，本报告期 无此业务；2）覆铜板及铜箔业务毛利率及盈利能力下降。 公司预计归属于上市公司股东的扣除非经常性损益的净利润比上年同期增长535.18%至661.78%，主要 原因是黄金价格持续上涨导致的成品金营业收入和毛利率增长。 ...

Core Viewpoint - The company, Xicet Testing (301306.SZ), forecasts a revenue of 300 million to 350 million yuan for 2025, a decrease from 389 million yuan in the previous year, and anticipates a net loss of 116 million to 165 million yuan, compared to a loss of 158 million yuan in the prior year [1] Group 1: Performance Forecast - The expected revenue for 2025 is between 300 million and 350 million yuan, down from 389 million yuan in the previous year [1] - The anticipated net loss for 2025 is projected to be between 116 million and 165 million yuan, compared to a loss of 158 million yuan in the previous year [1] - The forecasted non-recurring net loss for 2025 is estimated to be between 117 million and 166 million yuan, compared to a loss of 160 million yuan in the previous year [1] Group 2: Reasons for Performance Changes - The company has made strategic investments that have impacted short-term net profit, including capacity expansion and market development, leading to increased depreciation, personnel costs, and operational expenses [2] - The electronic assembly business has focused on optimizing customer structure, resulting in a significant decline in civilian product revenue, although losses have narrowed due to certifications obtained by its subsidiary [2] - Increased competition in certain areas of the inspection and testing market has posed challenges to pricing and gross margin, but the company has managed to control overall losses through improved service quality and internal management [2] - The company has strengthened accounts receivable management, with a notable increase in cash collection from reliable military clients, although high accounts receivable balances have led to provisions for bad debts impacting current profits [2]

Core Viewpoint - The company, Saimo Intelligent (300466.SZ), forecasts a net loss of 32 million to 45 million yuan for the year 2025, showing a significant reduction in losses compared to the previous year's loss of 86.6174 million yuan [1] Financial Performance - The expected net loss for 2025 is between 32 million and 45 million yuan, while the non-recurring net loss is projected to be between 40 million and 53 million yuan, compared to a loss of 95.7879 million yuan in the previous year [1] - The company has achieved a substantial reduction in losses year-on-year, primarily due to improved collection of accounts receivable and a significant decrease in credit impairment losses [1] Operational Efficiency - The company has enhanced operational efficiency, leading to noticeable improvements in the governance of loss-making enterprises and a significant reduction in asset impairment losses compared to the previous year [1] - Cost optimization and expense control measures have been further strengthened, resulting in a marked decrease in period expenses compared to the same period last year [1] Cash Flow - As of the end of the reporting period, the company reported a positive net cash flow from operating activities [1] - Non-recurring gains and losses had an impact of approximately 8 million yuan on net profit, mainly from government subsidies and gains from debt restructuring and equity disposal due to the exclusion of a controlling company [1]

Core Viewpoint - Hongyang (000525.SZ) is expected to report a net loss of 260 million to 390 million yuan for the year 2025, a significant shift from a profit of 388.06 million yuan in the same period last year, indicating a transition from profit to loss [1] Financial Performance - The anticipated net profit attributable to shareholders is expected to turn from profit to loss year-on-year, primarily due to the absence of substantial non-recurring gains that were recognized in the previous year following the company's judicial restructuring [1] - The company forecasts a continued net loss after excluding non-recurring gains, but with a significant reduction in the loss compared to the previous year, indicating a recovery in the main business operations [1] Operational Insights - The main business is showing a noticeable recovery, with an improvement in product gross margins, alongside a decrease in financial and management expenses, suggesting a gradual restoration of profitability [1]